Welcome to our dedicated page for IDEX news (Ticker: IEX), a resource for investors and traders seeking the latest updates and insights on IDEX stock.
IDEX Corporation (NYSE: IEX) is a global engineered products company serving critical industrial, health and science, and fire and safety markets. This news page aggregates company announcements, earnings releases and other corporate updates so readers can follow how IDEX executes its strategy across its three primary segments: Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products.
Visitors can review quarterly and annual financial results, where IDEX discusses segment performance, organic sales trends, acquisitions and platform optimization efforts. Earnings releases often highlight factors such as pricing, volume changes in end markets like life sciences, pharmaceuticals, aerospace and defense, semiconductors, water and fire and safety, as well as the impact of acquisitions including Mott Corporation and Micro-LAM, Inc.
The news feed also includes information on capital allocation decisions, such as regular quarterly cash dividend declarations and share repurchase authorizations, along with commentary on the company’s balanced deployment of free cash flow. Corporate governance and leadership updates, including appointments of senior executives, are disclosed through press releases and related Form 8-K filings and appear in this stream.
For investors tracking IEX stock, this page provides a centralized view of IDEX’s public communications, from webcast announcements for earnings calls to updates on its 8020 operating approach and growth platforms. Bookmark this page to access a chronological record of IDEX Corporation news and to monitor how management describes the company’s performance, portfolio evolution and role in critical industries over time.
In Q1 2023, IDEX Corporation reported record sales of $845 million, up 13% year-over-year, with organic growth of 6%. Earnings per share (EPS) rose to $1.84, a 1% increase, and adjusted EPS was $2.09, up 7%. Operating cash flow surged by 86% to $148 million, and free cash flow reached $121 million, up 91%. Despite strong overall performance, the company anticipates a negative revenue growth outlook for its Health & Science Technologies segment due to prolonged inventory correction, prompting a revision in 2023 adjusted EPS guidance to $8.25 to $8.55.
IDEX announced plans to acquire Iridian Spectral Technologies for 150 million Canadian dollars, enhancing its optical filters portfolio. Overall, the Q1 results reflect resilience amidst challenges, particularly in the HST segment.
IDEX Corporation (NYSE:IEX) has agreed to acquire Iridian Spectral Technologies for 150 million Canadian dollars, enhancing its optical coating capabilities. This strategic acquisition aims to bolster IDEX's product portfolio in optical filters, positioning the company to compete more effectively in key markets, including laser communications and life sciences. Iridian, expected to generate CAD 36 million in sales for the fiscal year 2023 with an EBITDA margin in the low 30s, will become part of IDEX's Health & Science segment. The acquisition is set to close later this quarter, pending customary conditions. CEO Eric Ashleman emphasized that this move aligns with IDEX's strategic growth plan.
IDEX Corporation (NYSE:IEX) has announced its upcoming first-quarter earnings conference call scheduled for April 27, 2023, at 9:30 a.m. CT. CEO Eric Ashleman and CFO William Grogan will present the financial results and address questions from analysts. The conference call can be accessed via the company's website, where presentation slides will also be available. An audio replay of the call will be offered until May 27, 2023. IDEX, a global firm with over $3 billion in annual sales, operates with nearly 9,000 employees across more than 20 countries, providing mission-critical components for various industries.
IDEX Corporation (NYSE: IEX) reported strong financial results for Q4 2022 and the full year, achieving record reported EPS of $7.71, up 31%, and adjusted EPS of $8.12, up 18%. Q4 sales reached $810.7 million, a 13% increase year-over-year, with overall orders totaling $803.4 million, up 1%. However, the net income margin decreased to 16.0%, down 60 basis points, influenced by increased costs from acquisitions and employee-related expenses. The company expects organic sales growth of 1-5% in FY 2023 and Q1 EPS guidance between $1.74 and $1.79, reflecting anticipated challenges from shipment delays and share-based compensation adjustments.
IDEX Corporation (NYSE:IEX) has scheduled its fourth quarter earnings conference call for February 1, 2023, at 9:30 a.m. CT. CEO Eric Ashleman and CFO William Grogan will discuss the company’s financial performance for Q4 and the full year 2022, followed by a Q&A session. Interested investors can listen live and view presentation slides on the company’s website. An archive of the call will be available afterward, with an audio replay accessible until March 1, 2023.
IDEX Corporation (NYSE:IEX) has completed the acquisition of Muon B.V., a micro-precision technology manufacturer based in the Netherlands. Muon specializes in creating precise flow paths for various industries, including medical technologies and semiconductor manufacturing. IDEX believes this acquisition aligns well with their mission-critical solutions and organizational values. The Muon Group will be integrated into IDEX's Health & Science Technology segment, providing new growth opportunities and synergies in precision-engineering applications.
IDEX Corporation (NYSE:IEX) has announced a quarterly cash dividend of $0.60 per common share, set to be paid on January 27, 2023, to shareholders of record as of January 13, 2023. This marks the company's 113th consecutive quarterly cash dividend payment. IDEX operates over 45 businesses globally, reporting nearly $2.8 billion in annual sales and employing more than 8,000 staff across more than 20 countries.
IDEX Corporation (NYSE: IEX) reported strong financial results for Q3 2022, featuring a record EPS of $2.36, up 56% year-over-year, and record sales of $824 million, a 16% increase. The company's operating margins improved, with a reported margin of 24.5%. Cash from operations reached $198 million, representing 111% of net income. IDEX also announced the acquisition of Muon Group for €700 million, aimed at bolstering its growth strategy. For 2022, the company raised its EPS guidance to $7.75-$7.80, expecting a 12% organic sales growth for the full year.
IDEX Corporation (NYSE:IEX) will host its third quarter earnings conference call on October 26, 2022, at 9:30 a.m. CT. CEO Eric Ashleman and CFO William Grogan will present the financial results and answer questions from investors. The call will be accessible via their website. An audio replay of the conference will be available until November 26, 2022. IDEX has nearly $2.8 billion in sales, operates over 45 businesses, and employs more than 8,000 people globally.
IDEX Corporation (NYSE: IEX) announced the appointment of Katrina L. Helmkamp as Non-Executive Chair of its Board of Directors, effective October 1, 2022. Helmkamp has been an independent director since November 2015 and has extensive global business experience, formerly serving as CEO of Lenox Corporation and as President and CEO of Cartus Corporation. She succeeds William M. Cook, who is retiring after 14 years. The Board's size will decrease from 11 to 10 directors.